Two-Way Link Between Type 2 Diabetes and Inflammatory Bowel Disease, finds Study Dr Riya Dave20 Nov 2025 8:45 PM ISTResearchers have found in a new study that type 2 diabetes mellitus (T2DM) and inflammatory bowel disease (IBD) are strongly and bidirectionally...
Higher estimated glucose disposal rate tied to Higher Testosterone levels and Lower Testosterone Deficiency in T2DM: Study Dr. Shravani Dali20 Nov 2025 9:00 AM ISTA study published in BMC Endocrine Disorders investigated the relationship between estimated glucose disposal rate (eGDR) and testosterone levels in...
Elevated TyG Index Predicts Hyperuricemia Risk in T2DM: Study Dr. Shravani Dali19 Nov 2025 8:45 PM ISTA study published in Frontiers in Endocrinology has found that an elevated triglyceride-glucose (TyG) index is independently associated with a higher...
Type 2 Diabetes in Pregnancy Linked to Higher Risk of Delivering Large-for-Gestational-Age Infants: Study Medha Baranwal19 Nov 2025 8:45 PM ISTChina: Pregnant women with type 2 diabetes mellitus (T2DM) who deliver large-for-gestational-age (LGA) infants face significantly higher risks of...
Retinopathy Severity Linked to Nerve and Kidney Damage in Type 2 Diabetes: Study Dr Riya Dave10 Nov 2025 8:45 PM ISTResearchers have found that the severity of diabetic retinopathy (DR) and the presence of diabetic macular edema (DME) are closely linked to both...
Sarcopenia in Asian Patients with Type 2 Diabetes Mellitus: A Growing Concern Dr. Shravani Dali10 Nov 2025 8:00 AM ISTA recent meta-analysis published in Journal of Diabetes Investigation by Xie et al. (2025) highlights the increasing burden of sarcopenia among Asian...
Indian Study Finds Vildagliptin SR Effective and Safe in Type 2 Diabetes Patients Uncontrolled on Metformin: PRIME-Vilda Trial Dr. Garima Soni30 Oct 2025 12:11 PM ISTVildagliptin SR 100 mg once daily has been shown to be effective and safe in improving glycemic control in Indian T2DM patients in India not...
Lowering Albuminuria Improves Survival and Kidney Outcomes in Diabetes-Related CKD: Study Dr. Shravani Dali28 Oct 2025 9:15 PM ISTA recent analysis published in BMJ Open Diabetes Research & Care revealed that reducing albuminuria plays a crucial role in improving long-term...
Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet Susmita Roy14 Oct 2025 5:23 PM ISTNew Delhi: Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC), functioning under the Central Drug Standard Control...
Vildagliptin-Dapagliflozin FDC Effective in High CV Risk Indian T2DM Patients: Findings from Latest DAa-ViNCI Study Dr. Bhumika Maikhuri6 Oct 2025 12:22 PM ISTIn a new study, fixed-dose combination (FDC) of vildagliptin and dapagliflozin demonstrated substantial efficacy and good tolerability in managing...
Empagliflozin exhibits Safety and Renal Effects in Cirrhosis With T2DM: Study Dr. Shravani Dali26 Sept 2025 8:30 AM ISTA new clinical study has explored the role of empagliflozin in patients living with cirrhosis and type 2 diabetes mellitus, highlighting both its...
Lower Irisin Levels Linked to Diabetic Nephropathy Progression in T2DM: Study Dr. Shravani Dali18 Sept 2025 11:00 AM ISTA newly published study suggests that lower circulating irisin levels in patients with type 2 diabetes (T2DM) are associated with impaired renal...
